The evolving landscape of CDK inhibitor use in breast cancer therapy and beyond

Nature Reviews Drug Discovery 2026

View at publisher

Authors: Erik S. Knudsen, Agnieszka K. Witkiewicz, Sheheryar Kabraji

DOI: 10.1038/s41573-026-01431-5

Cited by: 5

References: 195

Fields of Study & Subjects

Advanced Breast Cancer Therapies Cancer-related Molecular Pathways HER2/EGFR in Cancer Research

References 195